Study identifies molecular drivers of cerebral small vessel disease
A new study identifies molecular factors that promote small vessel disease – and an active drug that can…
Epigenetic drift explains why the aging intestine becomes more vulnerable to cancer
Researchers from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, Germany, the Molecular Biotechnology…
Understanding leptin’s dual function in MAFLD pathogenesis
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with…
Stem Cell Research Discovers Two Cells That Could Lead To Regenerating Teeth And Bone
Tooth loss and bone degeneration are problems that modern medicine still struggles to fix. Data from the National…
Stem Cell Research Discovers Two Cells That Could Lead To Regenerating Teeth And Bone
Tooth loss and bone degeneration are problems that modern medicine still struggles to fix. Data from the National…
GPR120 plays a key role in mediating the effects of n-3 fatty acids on mammary function
Background During lactation, the mammary gland undergoes significant structural and functional changes to produce milk, which is essential…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…
Exploring the genetic and clinical landscape of clubfoot
A new publication offers an extensive examination of clubfoot, a congenital deformity known as congenital talipes equinovarus (CTEV),…
Researchers classify how specific genetic mutations correspond to rare disorders
The NF-κB signaling pathway plays a pivotal role in how our bodies fight infection, heal, and regulate inflammation.…
NKAPL identified as a tumor suppressor and therapeutic target in NSCLC
Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at…